Hybrid deep learning model for detection and classification of lung cancer fusion images using MCNet

Abstract

Lung cancer is a dangerous tumor that requires accurate diagnosis for effective treatment. Traditional diagnosis involves invasive and time-consuming histologic examination, and radiologists face challenges in localizing lung tumors. Deep neural convolutional networks are frequently used to locate lung cancer, but this is still difficult when not accounting for surrounding lung tissue. Despite progress in research, healthcare still uses deep learning models to improve the precision and sensitivity of large datasets. CNN (Convolutional Neural Network) accuracy standards are adequate, but image properties such as flips, construction, and other uncommon alignments diminish its efficiency. CNN also does not store the geometric distribution between scanned picture features. CT (Computed Tomography) and PET (Positron Emission Tomography) scans require a method that takes into consideration the spatial information of picture characteristics, as they are vulnerable to alignment problems during the perusing process. To address these issues, the authors propose MCNet (MobileNetV2 with Capsule Network), a hybrid network that adopts feature extraction and categorization from MobileNetV2, and capsule network is used to overcome the limitations of convolutional neural networks (CNNs) when it comes to processing images with abnormal orientations, such as tilting or rotation. Although CNNs are effective in processing images presented in a standard orientation, they have difficulty handling variations in image orientation. In this work, MobileNetV2 serves as a backbone network for Capsule Networks in lung cancer diagnosis. The lung image collection dataset verifies the effectiveness of MCNet, and experimental results show that MCNet technology performs better than previous state-of-the-art techniques. The proposed hybrid MCNet architecture achieves the clinical goal of lung cancer diagnosis with a lower computational cost, reducing processing time complexity and false positive rates compared to current techniques.